Amanote Research
Register
Sign In
Short-Term Treatment for Acute Myelogenous Leukaemia.
BMJ
doi 10.1136/bmj.284.6324.1221
Full Text
Open PDF
Abstract
Available in
full text
Date
April 24, 1982
Authors
R Bell
A Z Rohatiner
M L Slevin
J M Ford
H S Dhaliwal
G Henry
B G Birkhead
J A Amess
J S Malpas
T A Lister
Publisher
BMJ
Related search
Acute Myelogenous Leukaemia in an Adult Presenting With Uveitis
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Chronic Myelogenous Leukaemia (CML)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Hypoparathyroidism and Hypocalcaemia During Treatment for Acute Leukaemia.
BMJ
Conception and Congenital Abnormalities After Chemotherapy of Acute Myelogenous Leukaemia in Two Men.
BMJ
Treatment of Acute Myelogenous Leukemia in Older Adults
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
New Agents for Acute Myelogenous Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Generation of Adherent Lymphokine Activated Killer (A-Lak) Cells From Patients With Acute Myelogenous Leukaemia
British Journal of Cancer
Cancer Research
Oncology
Aminopterin in the Treatment of Acute Leukaemia
BMJ
Razoxane in Treatment of Acute Myeloid Leukaemia.
BMJ
